Following regulatory approval by the Singapore Food Agency (SFA) in 2024, The Protein Brewery is now actively launching Fermotein into Singapore and is looking for local commercial and R&D partners to scale faster. As part of this new focus The Protein Brewery will also exhibit their new innovations at the Agri-Food Tech Expo Asia during the Singapore Food Week.
This investment round welcomed new investors Invest-NL and the Brabant Development Agency (BOM), alongside existing investors Novo Holdings, Unovis Asset Management, and Madeli.
Meer weten?
Scaling Up and Strengthening Global Position
Following its Series A round four years ago, The Protein Brewery has laid the groundwork to commercialize Fermotein at scale. This new funding will be used to:
- Strengthening sales and application expertise, ensuring Fermotein meets the needs of food manufacturers worldwide.
- Commercialize Fermotein in the United States and Singapore, accelerating business growth in key market segments.
- Expand production at the Mijkenbroek facility, solidifying our readiness for large-scale commercialization.
- Develop the Fermotein innovation platform, unlocking new possibilities in nutrition and product applications.
Fermotein: A New Frontier in Food
Innovation Fermotein is a high-protein, high-fiber ingredient that integrates seamlessly into baked goods & snacks, dairy alternatives like yogurts and nutritional products like protein shakes, functional bars and meal replacement drinks due to its tasteless and odourless nature. Unlike many alternative proteins that require high capital investment, Fermotein’s production process is significantly less capital-intensive, allowing for more cost-efficient scaling.
Central to this scalability is The Protein Brewery’s proprietary fungal strain exclusively leveraged for mycoprotein. Its patented process enables low capital investment and cost-effective production, overcoming key industry hurdles that have long limited the affordability and scalability of alternative proteins.
Beyond versatility and scalability, Fermotein delivers a unique blend of high-quality protein and essential fibers. The Protein Brewery is exploring its role in satiety and metabolic health, particularly GLP-1 pathways.
The Protein Brewery is launching Fermotein with several customers in the USA in the coming months and is also expanding its business in Singapore. Key focus areas are health & wellness and active nutrition which is an important trend for Singapore as well. "We see this as a defining moment—not just for The Protein Brewery, but for the next generation of the food ecosystem. The future of protein is about quality, nutrition, and sustainability, and this funding ensures we will play a key role in that future," said Thijs Bosch.
